Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
Di Costanzo F, Malacarne P, Zironi S, Marzola M, Cornia E, Figoli F, Bacchi M, Passalacqua R, Algeri R, Bartolucci R. Di Costanzo F, et al. Among authors: bartolucci r. J Surg Oncol Suppl. 1991;2:137-40. doi: 10.1002/jso.2930480529. J Surg Oncol Suppl. 1991. PMID: 1892522 Clinical Trial. No abstract available.
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
Rinaldi M, Crinò L, Scagliotti GV, Mosconi AM, De Marinis F, Gridelli C, Selvaggi G, Della Giulia M, Darwish S, Porrozzi S, Novello S, Cipri A, Bartolucci R, Calandri C, Tonato M. Rinaldi M, et al. Among authors: bartolucci r. Ann Oncol. 2000 Oct;11(10):1295-300. doi: 10.1023/a:1008334610955. Ann Oncol. 2000. PMID: 11106119 Free article. Clinical Trial.
Cisplatin and low-dose cytosine arabinoside in advanced cancer.
Di Costanzo F, Brugia M, Padalino D, Maragoni M, Proietti MG, Bartolucci R, Buzzi F. Di Costanzo F, et al. Among authors: bartolucci r. Tumori. 1987 Oct 31;73(5):493-7. doi: 10.1177/030089168707300511. Tumori. 1987. PMID: 3686682
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators. Goldman JW, et al. Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4. Lancet Oncol. 2021. PMID: 33285097 Clinical Trial.
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
Gridelli C, Perrone F, Gallo C, De Marinis F, Ianniello G, Cigolari S, Cariello S, Di Costanzo F, D'Aprile M, Rossi A, Migliorino R, Bartolucci R, Bianco AR, Pergola M, Monfardini S. Gridelli C, et al. Among authors: bartolucci r. Eur J Cancer. 1997 Mar;33(3):392-7. doi: 10.1016/s0959-8049(97)89011-9. Eur J Cancer. 1997. PMID: 9155522 Clinical Trial.
49 results